Drugs used in Dyslipidemia Flashcards
Fibric Acid Derivatives
• MOA
• Name them
MOA:
• Act as Ligands to for PPARa nuclear receptor
• PPARa turns on processes that help to get rid of TGs
(increased FA use in muscle, inc. apoA1/2, dec. apo CIII, inc. LDL-R)
Drugs:
• Gemfibrozil
• Fenofibrate
• Fenofibric Acid
**Statins
• MOA
• Name them
Blockage of Cholesterol Synthesis
• Competitive inhibitor of HMG-CoA Reductase
Increased LDL receptors
• causes SREBP to go from ER to Golgi and Finally to act as a transcription factor to up regulate LDLR synthesis
Drugs = Lo-SPAR:
• Lovastatin
• Simvastatin
• Pravastatin
• Atrovastatin
• Rosuvastatin
**Bile Acid Resins
• MOA
• Name them
MOA:
• Anionic ion exchange resins (they are Positively charged)
• Bind up bile acids and prevent recycling
• Cholesterol must then be pulled out of the blood to make new bile acids
Drugs:
• Colestipol
• Cholestyramine
• Coleevelam
**Ezetimibe
• MOA
• Method of administration
MOA:
• Prevents uptake of CHOLESTEROL itself in SMALL INTESTINE and leaves the bile alone
• Decreased Cholesterol uptake cause liver to UPREGULATE LDL Receptors
*Given as a pill
**Niacin
• MOA
• Name them
MOA:
• Reduces Hepatic Triglyceride Synthesis
• Reduces Hepatic ApoB synthesis
• Enhances Macrophage transfer of Cholesterol to HDL
• Promotes VLDL conversion to LDL
Name:
• Niacor - IR
•Niaspan - ER
How much can statins lower LDL compared to other drugs such as Bile acid resins, ezetimibe, or niacin?
Statins lower LDL by 25-60% while other drugs lower it by ~20%
Which statins are acted on by CYP3A4?
• Note any important differences
• Lovastatin
• Simvastatin
• Atorvastatin
**Atorvastatin is also metabolized by ß-oxidation so CYP3A4 interactions typically aren’t an issue
Which statins are the most effective at lowering cholesterol?
- How effective are they?
- What type of patients would you typically give these to?
• Atorvastatin
• Rosuvastastin
*Can give AT LEAST a 50% reduction in cholesterol **Typically given to patients who have lots of risk factors such as those with diabetes or heart disease**
What statin would you consider giving to a patient with renal dysfunction?
• if this drug were not available, what backup would you use?
• Metabolism of these drugs?
Atorvastatin (only 2% renal excretion)
• ß-oxidation and CYP3A4 metabolized
Fluvastatin (only 5% renal excretion)
• CYP2C9, hydoxylation, and ß-oxidation
What statins are acted on by CYP2C9?
Rosuvastatin
• CYP2C9, Fecal excretion
Fluvastatin
• CYP2C9, Hydroxylation, ß-oxidation
Of the statins which are most susceptible to drug-drug interactions and why?
Simvastatin and Lovastatin
• Both are metabolized primarily by CYP3A4
What are some drugs that inhibit CYP3A4?
• Macrolides
• Azole Antifungals
• Calcium Channel Blockers
• Grapefruit
• HIV protease Inhibitors
• Immunosuppressants
What is the risk of Rhabdomyolysis other than severe muscle pain?
• indicators that this is happening
Indicators:
• Very High Levels of CPK
• Tea colored Urine
Risk:
• Myoglobin released from damaged muscle is nephrotoxic and can damage Kidneys
What are some drugs that inhibit p-glycoprotein mediated intestinal reabsorption?
• Cyclosporin
• Grapefruit Juice
What drug should you not use with any of the statins and why?
Gemfibrozil - contraindicated
• Inhibits glucuronyltranserase-1 and glucuronidation used as one of the methods of elimination for almost all of the statins
How does myositis differ from Rhabdomyolysis?
Both result in high CPK and muscle pain, but Rhabdomyolysis is so severe that it can cause increased risk of Renal failure and death
Which of the statins has the lowest risk of drug-drug interactions and why?
Pravistatin
• Eliminated via Sulfation, Oxidation, and Gluroonidation
Lovastatin Simvastatin
• Metabolism
• Systemic Bioavailability
Metabolism
•CYP3A4
• Glucoronidation
Bioavailability:
• 5% (lowest)
Pravastatin
• Metabolism
• Systemic Bioavailability
Metabolism
• Sulfation
• Oxidation
• Glucoronidation
Bioavailability:
• 17%
Fluvastatin
• Metabolism
• Systemic Bioavailability
Metabolism
• CYP2C9
• Hydroxylation
• ß-oxidation
Bioavailability
• 24%
Atorvastatin
• Metabolism
• Systemic Bioavailability
Metabolism
• ß-oxidation
• CYP3A4
• Glucoronidation
Bioavailability
• 14%